Perceptive Capital Solutions CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Harlan Waksal, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Kenneth Song, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Perceptive Capital Solutions Holdings reported changes in beneficial ownership of Perceptive Capital Solutions Corp common stock on July 20, 2026.
NASDAQ
Perceptive Advisors Llc and 2 others reported changes in beneficial ownership of Perceptive Capital Solutions Corp common stock on July 20, 2026.
NASDAQ
Mark C. Mckenna, Former Director of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Adam Leo Stone, Former Dir, Ofc, 10% Ownr of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Michael Seth Altman, Former Dir, Ofc, 10% Ownr of Perceptive Capital Solutions Corp, reported multiple transactions in common stock on July 20, 2026.
NASDAQ
Ra Capital Management, L.P. and 6 others reported changes in beneficial ownership of Perceptive Capital Solutions Corp common stock on July 20, 2026.
NASDAQ
Perceptive Capital Solutions Corp announced the approval of key proposals at its July 15, 2026, extraordinary general meeting, paving the way for a business combination.
NASDAQ
Freenome Holdings, Inc. announced that its SimpleScreen CRC v2 test met primary and secondary endpoints, demonstrating improved detection of advanced precancerous lesions while maintaining colorectal cancer sensitivity.
NASDAQ
Freenome announces updated SimpleScreen CRC blood test met all primary and secondary endpoints in a pivotal clinical validation study, showing significant improvements in detecting advanced precancerous lesions.
NASDAQ
Perceptive Capital Solutions Corp has postponed its extraordinary general meeting to July 15, 2026, to allow for supplemental disclosures and further proxy solicitation related to its business combination with Freenome Holdings, Inc.
NASDAQ
Perceptive Capital Solutions Corp and Freenome Holdings, Inc. announced the SEC declared their registration statement effective for a proposed business combination, with a shareholder meeting set for July 9, 2026.
NASDAQ
Perceptive Capital Solutions Corp (PCSC) has extended its deadline to complete an initial business combination from June 13, 2026, to June 13, 2027, following shareholder approval.
NASDAQ
Freenome Holdings, Inc. and Perceptive Capital Solutions Corp. announced their agreement to merge, aiming to advance Freenome's AI-driven early cancer detection platform.
NASDAQ
Freenome Holdings, Inc. and Perceptive Capital Solutions Corp. (PCSC) have provided details regarding their proposed business combination, outlining the process for shareholder consideration and SEC filings.
NASDAQ
Freenome announced significant progress in its cancer detection programs, including the launch of its Early Access Program and strong clinical data, as it targets a mid-2026 de-SPAC with Perceptive Capital Solutions Corp.
NASDAQ
Perceptive Capital Solutions Corp and Freenome Holdings, Inc. outline the regulatory steps and significant risks associated with their proposed business combination.
NASDAQ
Freenome Holdings, Inc. announced a definitive business combination agreement with Perceptive Capital Solutions Corp and a $240 million PIPE financing, aiming for a Nasdaq listing in H1 2026.
NASDAQ
Perceptive Capital Solutions Corp. announces upcoming SEC filings and shareholder solicitation for its proposed business combination with Freenome Holdings, Inc.
NASDAQ
Freenome Holdings, Inc., an early cancer detection company, will merge with Perceptive Capital Solutions Corp (PCSC) to become a publicly listed entity on Nasdaq under the ticker symbol FRNM, backed by a $240 million PIPE financing.
NASDAQ
Perceptive Capital Solutions Holdings purchased 286,250 Class A ordinary shares of Perceptive Capital Solutions Corp in a private placement at $10 per share.
NASDAQ
Adam Stone, CEO of Perceptive Capital Solutions Corp, reports the acquisition of 286,250 Class A ordinary shares through Perceptive Capital Solutions Holdings.
NASDAQ
Michael Altman, Chief Business Officer and Director of Perceptive Capital Solutions Corp, reports the acquisition of 286,250 Class A ordinary shares through Perceptive Capital Solutions Holdings.